5-Bromo-1H-indazol-3-amine(CAS: 61272-71-7)

5-Bromo-1H-indazol-3-amine (CAS: 61272-71-7) requires adherence to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for proper hazard communication and handling. In the European Union, it must comply with REACH regulations for registration, evaluation, and authorization of chemicals. FDA and EPA may require specific documentation and handling procedures for its use in pharmaceutical and environmental applications.

Alternatives to 5-Bromo-1H-indazol-3-amine (CAS: 61272-71-7) for synthesis include related indazole derivatives with different substituents, such as 5-chloro-1H-indazol-3-amine or 5-fluoro-1H-indazol-3-amine. Other potential substitutes include pyrazolones and benzimidazoles, which can serve similar functional roles in organic synthesis.

Research interest in 5-Bromo-1H-indazol-3-amine (CAS: 61272-71-7) is growing due to its potential as an intermediate in drug discovery and synthesis of biologically active compounds. Market trends indicate increasing demand in pharmaceutical and chemical industries. Emerging studies focus on its biological activities and potential applications in therapeutics.

Waste containing 5-Bromo-1H-indazol-3-amine (CAS: 61272-71-7) should be collected in appropriately labeled containers and disposed of via incineration or professional waste disposal services. Ensure that waste handling complies with local, national, and international regulations to minimize environmental impact and occupational hazards. Proper safety precautions, including personal protective equipment, should be followed during waste disposal operations.